Palgrave Communications – the multi and interdisciplinary, open access journal published by Palgrave Macmillan, part of Springer Nature – is currently inviting article proposals and full papers for a new research article series, entitled ‘Making the cut? Scientific Possibilities and Ethical, Legal and Social Implications and Challenges in Genome-Editing’. This is being edited by Dr Oliver Feeney (National University of Ireland – Galway, Ireland), Dr Brígida Riso (ISCTE-University Institute of Lisbon, Portugal) and Professor Vojin Rakic (University of Belgrade, Serbia).
To register interest prospective authors should submit a short article proposal (abstract summary) to the Editorial Office in the first instance. Full submissions can be submitted any time up until the end of July 2019.
Since 2012, the dramatically increased potential of genome editing techniques (particularly CRISPR-Cas9) in human therapeutics has created headlines, enthusiasm and concern in genetic research not seen since the mapping of the human genome at the turn of the century. It could be suggested that the recent developments in genome editing do not bring entirely new ethical, social and legal issues to the fore. Rather, it brings us to a point where many of these theoretical reflections are becoming (potentially) applicable and therefore can have a greater role to play in policy decisions, which will affect the emerging governance of new genome editing developments.
In order to help move forward a responsible debate on the issue of genome-editing with a focus on human applications and to foster a discussion that is critically reflective on existing responses from academia, policy-makers, business and the media, this collection will bring together a multidisciplinary collection of key perspectives, charged with three key tasks. Firstly, a key task is to contribute to the question of how to evaluate and guide current and imminent developments in genome editing. Secondly, a closely related task is to contribute to reviewing the existing theoretical literature on the ethical, legal and social considerations of genetic interventions on human beings that has developed over the past number of decades, in order to ascertain their suitability for contemporary genome editing evaluation and guidance. The third task aims to develop a robust framework for future discussions and evaluations on genome editing developments and to contribute toward a responsible governance framework for scientists, biotech companies and public research institutions in Europe, and beyond, as well as improving the discourse between key stakeholders, including scientists, clinicians, bioethicists, policy-makers and the wider society.
We invite papers, both empirical and theoretical, from a wide range of disciplines, including, but not restricted to, philosophy, ethics, law, medical humanities, politics and social sciences, that:
- Evaluate current and/or imminent developments in genome editing with regard to human interventions or non-human interventions with clear consequences for human well-being.
- Contribute to reviewing the existing theoretical literature on the ethical, legal and social considerations of such interventions.
- Contribute to discussion of the adaptability of the previous literature and framework to the contemporary genome-editing scene.
- Map and compare the speculation involving genome editing to the effective and concrete developments achieved so far.
- Develop a robust framework for future discussions and evaluations on genome editing developments and to contribute toward a responsible governance framework for scientists, biotech companies and public research institutions in Europe, and beyond.
- Contribute to public engagement strategies on improving the discourse between key stakeholders, including scientists, clinicians, bioethicists, policy-makers and the wider society.
More details can be found here.